Calcium and Vitamin D Test in Delhi

Calcium + Vitamin D Test at Home (Serum Calcium & 25-Hydroxy Vitamin D)

The Calcium + Vitamin D test brings together two of the most closely linked markers in bone and mineral metabolism. Serum calcium measures the circulating calcium level that the body maintains within a precise physiological window. The vitamin D component -  specifically 25-hydroxyvitamin D (25-OH-D), also called calcidiol -  measures the stored form of vitamin D that best reflects an individual's overall vitamin D status across all sources and over recent weeks and months.

The connection between these two markers is fundamental and bidirectional. Vitamin D is essential for intestinal calcium absorption. When vitamin D levels fall, the gut absorbs less calcium from food, serum calcium begins to drop, and the body compensates by releasing parathyroid hormone (PTH), which mobilises calcium from bone to maintain blood levels. Over time, if vitamin D deficiency persists, this compensatory mechanism progressively depletes skeletal calcium reserves, contributing to osteoporosis, osteomalacia, and fracture risk.

MAX@Home makes this panel available at your doorstep through a single blood draw collected by a certified phlebotomist at your preferred time. Samples are processed at a partner NABL-accredited laboratory, and your digital authenticated report is delivered within 24 to 48 hours, enabling you and your doctor to act quickly on the findings.

What Serum Calcium Measures

Calcium is indispensable for bone structure, nerve conduction, muscle contraction, cardiac rhythm, blood clotting, and enzyme function. The body maintains serum calcium within a narrow physiological range (8.5 to 10.5 mg/dL) through a finely tuned hormonal system involving PTH, calcitriol (the active form of vitamin D), and calcitonin, acting coordinately on bone, kidneys, and intestine.

Total serum calcium reflects three fractions: albumin-bound calcium (approximately 40 percent), calcium complexed with anions such as citrate and bicarbonate (about 10 percent), and free ionised calcium (approximately 50 percent), which is the physiologically active form. In patients with low albumin -  common in malnutrition, chronic illness, or liver disease -  total calcium can appear artificially low even when ionised calcium is normal. A corrected calcium formula accounts for this.

What abnormal calcium levels indicate in the context of vitamin D testing

Hypercalcaemia (calcium above 10.5 mg/dL) in the context of a vitamin D panel most commonly signals vitamin D toxicity from excessive supplementation, primary hyperparathyroidism, or, less commonly, granulomatous disease or malignancy. Identifying hypercalcaemia in a patient taking vitamin D supplements is a critical finding because continued supplementation in this setting can cause renal damage, nephrocalcinosis, and soft tissue calcification.

Hypocalcaemia (calcium below 8.5 mg/dL) alongside low vitamin D is the classic biochemical picture of nutritional deficiency or malabsorption. In this pattern, hypocalcaemia confirms the deficiency is functionally significant; the body can no longer maintain calcium levels from dietary sources alone and is drawing calcium from bone reserves at the cost of skeletal integrity.

What 25-Hydroxy Vitamin D Measures

Vitamin D is unusual among vitamins in that the body can synthesise it endogenously in the skin through ultraviolet B radiation from sunlight. Whether derived from skin synthesis or from dietary and supplemental sources, vitamin D undergoes two hydroxylation steps to become biologically active. The first step, in the liver, produces 25-hydroxyvitamin D (25-OH-D). The second step, in the kidneys, produces 1,25-dihydroxyvitamin D (calcitriol), the hormonally active form.

Measuring 25-OH-D is the established standard for assessing vitamin D status because it has a long circulating half-life of two to three weeks, is present at much higher concentrations than calcitriol, and best reflects cumulative vitamin D input from all sources over the preceding weeks and months. Calcitriol, while biologically potent, has a short half-life and is tightly regulated by PTH and phosphate, making it a poor indicator of overall vitamin D reserve.

Interpreting 25-OH-D levels

• Below 20 ng/mL (50 nmol/L): deficient, with increased risk of rickets in children, osteomalacia in adults, bone loss, and secondary hyperparathyroidism.
• 20 to 30 ng/mL (50 to 75 nmol/L): insufficient, suboptimal for bone health and immune function; supplementation is generally recommended.
• 30 to 80 ng/mL (75 to 200 nmol/L): sufficient, associated with optimal bone health outcomes in most clinical populations.
• Above 100 ng/mL (250 nmol/L): potentially toxic range, associated with hypercalcaemia and hypercalciuria from excessive supplementation; dose review warranted.

Why Test Calcium and Vitamin D Together

Testing both markers together provides a more clinically complete picture than either alone:

• Low vitamin D with low or low-normal calcium confirms clinically significant deficiency with functional calcium impact; both vitamin D and calcium repletion are needed.
• Low vitamin D with a normal calcium may mean the body is compensating adequately through secondary hyperparathyroidism; adding a PTH measurement would complete this picture.
• Normal or high vitamin D with hypercalcaemia in a patient on supplements raises immediate concern for vitamin D toxicity and warrants prompt dose reduction.
• During vitamin D replacement therapy, measuring both markers at follow-up assesses whether calcium has normalised alongside vitamin D, confirming the treatment dose is adequate and not excessive.
• For osteoporosis workup, both values together help distinguish primary osteoporosis from osteomalacia. The latter shows low calcium alongside low vitamin D and elevated ALP and PTH, and requires a different treatment approach.

Vitamin D considerations in special populations

Several groups face disproportionately high risk and benefit from regular monitoring with this panel. Post-menopausal women face oestrogen-withdrawal bone loss compounded by vitamin D insufficiency. The elderly have reduced skin synthesis capacity, less sun exposure, and reduced dietary variety. Patients with malabsorption conditions (coeliac disease, inflammatory bowel disease, short bowel syndrome, or post-bariatric surgery) absorb both calcium and vitamin D poorly from the gut. Exclusively breastfed infants receive inadequate vitamin D from breast milk alone. Patients on corticosteroids, anticonvulsants, or rifampicin have accelerated vitamin D catabolism.

Conditions This Panel Evaluates

Vitamin D Deficiency and Insufficiency

Vitamin D deficiency (25-OH-D below 20 ng/mL) is the most common positive finding from this panel. Clinical presentations range from entirely asymptomatic in mild-to-moderate deficiency to bone pain, proximal muscle weakness, fatigue, and impaired immune function in more pronounced deficiency. In children, severe deficiency causes rickets with characteristic skeletal deformities including bowing of the legs and rachitic rosary. In adults, the equivalent is osteomalacia -  the bone matrix is present but inadequately mineralised, causing diffuse bone pain and fractures disproportionate to the degree of bone density loss.

Osteoporosis

Osteoporosis, characterised by low bone mineral density and microarchitectural deterioration, has multiple contributory factors, with vitamin D insufficiency and reduced calcium absorption being significant among them. Post-menopausal women and elderly men are at highest risk. This panel establishes whether vitamin D insufficiency is contributing to the bone loss identified on densitometry, guiding supplementation alongside anti-resorptive or anabolic treatments.

Hypoparathyroidism

Hypoparathyroidism, insufficient PTH production (most commonly after thyroid or parathyroid surgery or from autoimmune destruction of the parathyroid glands), causes hypocalcaemia alongside reduced renal activation of vitamin D. It presents with neuromuscular symptoms including perioral and peripheral tingling, muscle cramps, and in severe cases tetany and seizures. The Calcium + Vitamin D panel identifies low calcium; PTH measurement then distinguishes hypoparathyroidism from other hypocalcaemic causes.

Malabsorption Syndromes

Conditions impairing fat-soluble vitamin absorption from the gut (coeliac disease, Crohn disease, exocrine pancreatic insufficiency, short bowel syndrome, and post-bariatric surgery) reliably cause vitamin D and calcium malabsorption. This panel provides both the initial screening assessment and a monitoring framework for ongoing supplementation adequacy in these patients.

Monitoring Vitamin D Supplementation

Vitamin D supplementation is increasingly prescribed and increasingly self-initiated. Without monitoring, there is a risk of both under-treatment (deficiency persists) and over-treatment (hypercalcaemia from toxicity). This panel simultaneously assesses the adequacy of the vitamin D response and the safety of the calcium level, making it the appropriate surveillance test for all patients on supplementation.

Who Should Get This Test

• Post-menopausal women undergoing bone health assessment or osteoporosis risk evaluation.
• Elderly individuals with bone pain, muscle weakness, or a history of falls and low-impact fractures.
• Patients on long-term corticosteroid therapy, anticonvulsants, or other medications that impair vitamin D metabolism.
• Those with malabsorption conditions such as coeliac disease, inflammatory bowel disease, or post-bariatric surgery.
• Individuals taking vitamin D supplements who need to confirm the current dose is achieving target levels without causing calcium toxicity.
• Patients with symptoms suggesting hypocalcaemia, such as muscle cramps, tingling, or tetanic contractions.
• Anyone undergoing a comprehensive bone health assessment or fracture risk evaluation.

How to Prepare for the Test

Fasting and supplementation timing

A fast of eight to ten hours is recommended, particularly if the panel is part of a broader metabolic screen that includes fasting glucose or lipids. Vitamin D levels themselves are not significantly affected by recent food intake; the fasting requirement primarily ensures consistency with any co-ordered parameters. Water is freely permitted and encouraged.

Supplementation and medication notes

• Do not take your vitamin D supplement on the morning of the test. Taking a dose immediately before the blood draw can transiently elevate 25-OH-D beyond your steady-state level.
• Inform your doctor and MAX@Home team about all supplements being taken -  specifically the dose and frequency of vitamin D and calcium preparations.
• If testing to establish a baseline before starting supplementation, the sample should be collected before the first supplementation dose.
• Inform the phlebotomist of all prescription medications, including corticosteroids, anticonvulsants, and immunosuppressants.

How to Book with MAX@Home

Getting your Calcium + Vitamin D test done at home requires no hospital visit.

1.  Book through the MAX@Home website or helpline and select the Calcium + Vitamin D combination panel.

2.  Choose a morning slot that falls within your overnight fasting window, ideally before your daily supplement dose.

3.  A certified phlebotomist arrives at your doorstep with sterile collection equipment.

4.  A single blood draw is taken and transported to the partner NABL-accredited laboratory.

5.  Your digitally authenticated report is delivered within 24 to 48 hours to your registered email or phone.

If you are monitoring vitamin D as part of an ongoing treatment plan, retaining and comparing your reports from each test date through the MAX@Home patient portal helps track your trajectory over time.